Warby Parker Inc. Increase (Decrease) in Accrued Liabilities
Warby Parker Inc. (WRBY) reported Increase (Decrease) in Accrued Liabilities of $10.86 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2026-08-06
- Warby Parker Inc. increase (decrease) in accrued liabilities for the quarter ending 2026-06-30 was -$1.34M, a 111.81% decline year-over-year.
- Warby Parker Inc. increase (decrease) in accrued liabilities for the quarter ending 2026-03-31 was $12.20M.
- Warby Parker Inc. increase (decrease) in accrued liabilities for the quarter ending 2025-12-31 was -$19.82M, a 391.82% decline year-over-year.
- Warby Parker Inc. increase (decrease) in accrued liabilities for the quarter ending 2025-09-30 was $6.38M.
- Warby Parker Inc. increase (decrease) in accrued liabilities for fiscal 2025 was -$2.69M, a 128.26% decline from fiscal 2024.
- Warby Parker Inc. increase (decrease) in accrued liabilities for fiscal 2024 was $9.52M.
- Warby Parker Inc. increase (decrease) in accrued liabilities for fiscal 2023 was -$8.90M, a 423.80% decline from fiscal 2022.
- Warby Parker Inc. increase (decrease) in accrued liabilities for fiscal 2022 was $2.75M, a 71.03% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accrued Liabilities 3 month | Increase (Decrease) in Accrued Liabilities 6 month | Increase (Decrease) in Accrued Liabilities 9 month | Increase (Decrease) in Accrued Liabilities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$1.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $10.86M 10-Q · filed 2026-08-06 | -$8.96M derived: sum of 3 quarters · filed 2026-08-06 | -$2.58M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $12.20M 10-Q · filed 2026-05-07 | -$7.62M derived: sum of 2 quarters · filed 2026-05-07 | -$1.24M derived: sum of 3 quarters · filed 2026-05-07 | $10.07M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$19.82M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$13.44M derived: sum of 2 quarters · filed 2026-02-26 | -$2.13M derived: sum of 3 quarters · filed 2026-08-06 | -$2.69M 10-K · filed 2026-02-26 |
| 2025-09-30 | $6.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $17.69M derived: sum of 2 quarters · filed 2026-08-06 | $17.13M 10-Q · filed 2025-11-06 | $23.93M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $11.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $10.75M 10-Q · filed 2026-08-06 | $17.55M derived: sum of 3 quarters · filed 2026-08-06 | $15.09M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$560.00K 10-Q · filed 2026-05-07 | $6.23M derived: sum of 2 quarters · filed 2026-05-07 | $3.77M derived: sum of 3 quarters · filed 2026-05-07 | $9.07M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $6.79M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $4.33M derived: sum of 2 quarters · filed 2026-02-26 | $9.63M derived: sum of 3 quarters · filed 2026-02-26 | $9.52M 10-K · filed 2026-02-26 |
| 2024-09-30 | -$2.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $2.84M derived: sum of 2 quarters · filed 2025-11-06 | $2.73M 10-Q · filed 2025-11-06 | -$4.96M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $5.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $5.19M 10-Q · filed 2025-08-08 | -$2.50M derived: sum of 3 quarters · filed 2026-02-26 | $7.91M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | -$108.00K 10-Q · filed 2025-05-08 | -$7.80M derived: sum of 2 quarters · filed 2026-02-26 | $2.61M derived: sum of 3 quarters · filed 2026-02-26 | -$1.18M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | -$7.69M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $2.72M derived: sum of 2 quarters · filed 2026-02-26 | -$1.07M derived: sum of 3 quarters · filed 2026-02-26 | -$8.90M 10-K · filed 2026-02-26 |
| 2023-09-30 | $10.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $6.62M derived: sum of 2 quarters · filed 2024-11-07 | -$1.21M 10-Q · filed 2024-11-07 | $5.86M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | -$3.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$11.62M 10-Q · filed 2024-08-08 | -$4.55M derived: sum of 3 quarters · filed 2025-02-27 | -$504.00K derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | -$7.83M 10-Q · filed 2024-05-09 | -$759.00K derived: sum of 2 quarters · filed 2025-02-27 | $3.29M derived: sum of 3 quarters · filed 2025-02-27 | -$2.92M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $7.07M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $11.12M derived: sum of 2 quarters · filed 2025-02-27 | $4.91M derived: sum of 3 quarters · filed 2025-02-27 | $2.75M 10-K · filed 2025-02-27 |
| 2022-09-30 | $4.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | -$2.16M derived: sum of 2 quarters · filed 2023-11-08 | -$4.32M 10-Q · filed 2023-11-08 | -$6.56M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | -$6.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$8.37M 10-Q · filed 2023-08-09 | -$10.61M derived: sum of 3 quarters · filed 2024-02-29 | $3.81M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | -$2.16M 10-Q · filed 2023-05-09 | -$4.40M derived: sum of 2 quarters · filed 2024-02-29 | $10.02M derived: sum of 3 quarters · filed 2024-02-29 | $9.42M derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | -$2.24M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $12.18M derived: sum of 2 quarters · filed 2024-02-29 | $11.57M derived: sum of 3 quarters · filed 2024-02-29 | $9.49M 10-K · filed 2024-02-29 |
| 2021-09-30 | $14.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $13.81M derived: sum of 2 quarters · filed 2022-11-10 | $11.72M 10-Q · filed 2022-11-10 | $17.15M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | -$601.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | -$2.69M 10-Q · filed 2022-08-11 | $2.74M derived: sum of 3 quarters · filed 2023-02-28 | |
| 2021-03-31 | -$2.09M 10-Q · filed 2022-05-16 | $3.34M derived: sum of 2 quarters · filed 2023-02-28 | ||
| 2020-12-31 | $5.43M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $16.60M 10-K · filed 2023-02-28 | ||
| 2020-09-30 | $11.17M 10-Q · filed 2021-11-12 | |||
| 2019-12-31 | $1.36M 10-K · filed 2022-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| National Vision Holdings, Inc. (EYE) | United States | $1.297B | |
| STAAR SURGICAL CO (STAA) | United States | $0.957B | 362.70 |
| RxSight, Inc. (RXST) | United States | $0.197B | |
| Innovative Eyewear Inc (LUCY) | United States | $0.008B | |
| Bausch & Lomb Corp (BLCO) | Canada | $6.008B | -34.58 |
| COOPER COMPANIES, INC. (COO) | United States | $10.533B | 24.09 |